Solriamfetol may be an effective alternative for managing ADHD in adults, trial shows

Although several medications are approved to treat attention-deficit/hyperactivity disorder (ADHD), some individuals experience limited benefits from the drugs or develop side effects from their use.

Europe’s battle against Aedes mosquitoes: growing threat of mosquito-borne diseases

Study described how cases of all types of mosquito-borne diseases are increasing in Europe.

June 26, 2023

Illumina details EC timeline, funding requirements for Grail divestment

Dive Brief: Illumina on Friday disclosed more details of the European Commission’s order to unwind its Grail acquisition, saying it will have 12 months, with

October 14, 2023

UpHealth Sells Cloudbreak Health Business to GTCR for $180M

What You Should Know: UpHealth, Inc. has entered into a definitive agreement to sell its wholly-owned subsidiary, Cloudbreak Health, LLC, to private equity firm GTCR

November 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.